» Articles » PMID: 3003388

Human Papillomavirus Type 16 DNA-induced Malignant Transformation of NIH 3T3 Cells

Overview
Journal J Virol
Date 1986 Feb 1
PMID 3003388
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

A biological function for human papillomavirus 16 (HPV 16) DNA was demonstrated by transformation of NIH 3T3 cells. HPV 16 DNA has been found frequently in genital cancer and has been classified as a papillomavirus on the basis of DNA homology. A recombinant HPV 16 DNA (pSHPV16d), which contains a head-to-tail dimer of the full-length HPV 16 genome, induced morphologic transformation; the transformed cells were tumorigenic in nude mice. Expression of transforming activity was unique because of the long latency period (more than 4 weeks) required for induction of morphologic transformation and because the transfected DNA existed primarily in a multimeric form with some rearrangements. Furthermore, virus-specific RNAs were expressed in the transformants. The transformation of NIH 3T3 cells provides a model for analyzing the functions of HPV 16, which is associated with cervical carcinomas.

Citing Articles

Too many cooks in the kitchen: HPV driven carcinogenesis - The result of collaboration or competition?.

Kathleen W Tumour Virus Res. 2024; 19():200311.

PMID: 39733972 PMC: 11753912. DOI: 10.1016/j.tvr.2024.200311.


The Involvement of Human Papilloma Virus in Gastrointestinal Cancers.

Baj J, Forma A, Dudek I, Chilimoniuk Z, Dobosz M, Dobrzynski M Cancers (Basel). 2022; 14(11).

PMID: 35681587 PMC: 9179480. DOI: 10.3390/cancers14112607.


The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis.

Basukala O, Banks L Viruses. 2021; 13(10).

PMID: 34696321 PMC: 8541208. DOI: 10.3390/v13101892.


Mutagenic Potential ofBos taurus Papillomavirus Type 1 E6 Recombinant Protein: First Description.

Araldi R, Mazzuchelli-de-Souza J, Modolo D, Souza E, de Melo T, Spadacci-Morena D Biomed Res Int. 2016; 2015:806361.

PMID: 26783529 PMC: 4689895. DOI: 10.1155/2015/806361.


Fusion protein vaccines targeting two tumor antigens generate synergistic anti-tumor effects.

Cheng W, Chang M, Sun W, Jen Y, Liao C, Chen Y PLoS One. 2013; 8(9):e71216.

PMID: 24058440 PMC: 3772923. DOI: 10.1371/journal.pone.0071216.


References
1.
Law M, Byrne J, Howley P . A stable bovine papillomavirus hybrid plasmid that expresses a dominant selective trait. Mol Cell Biol. 1983; 3(11):2110-5. PMC: 370077. DOI: 10.1128/mcb.3.11.2110-2115.1983. View

2.
Nakabayashi Y, Chattopadhyay S, Lowy D . The transforming function of bovine papillomavirus DNA. Proc Natl Acad Sci U S A. 1983; 80(19):5832-6. PMC: 390169. DOI: 10.1073/pnas.80.19.5832. View

3.
Pfister H . Biology and biochemistry of papillomaviruses. Rev Physiol Biochem Pharmacol. 1984; 99:111-81. DOI: 10.1007/BFb0027716. View

4.
DiMaio D, Corbin V, Sibley E, Maniatis T . High-level expression of a cloned HLA heavy chain gene introduced into mouse cells on a bovine papillomavirus vector. Mol Cell Biol. 1984; 4(2):340-50. PMC: 368701. DOI: 10.1128/mcb.4.2.340-350.1984. View

5.
Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H . A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 1984; 3(5):1151-7. PMC: 557488. DOI: 10.1002/j.1460-2075.1984.tb01944.x. View